Clinical Trial Update: A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinorelbine plus capecitabine with trastuzumab for HER2-positive breast cancer after neoadjuvant chemotherapy; status currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN